Search in:

Advanced search

Leukemia & Lymphoma Volume 50, 2009 - Issue 12

Submit an article Journal homepage

124

Views

CrossRef citations to date

Altmetric

Original Articles: Clinical

Is inactivation of O⁶-methylguanine DNA methyltransferase still a favorable prognostic factor of patients with diffuse large B-cell lymphoma in the era of R-CHOP chemotherapy?

Gyeong-Won Lee;Division of Hematology–Oncology, Department of Internal Medicine, Gyeongsang National University School of Medicine, Jinju, Republic of Korea

Jung-Hun Kang;Institute of Health Science, Gyeongsang National University School of Medicine, Jinju, Republic of Korea

In-Suk Kim;Gyeongnam Regional Cancer Center, Jinju, Republic of Korea

Hoon-Gu Kim;Department of Laboratory Medicine

Gyung Hyuck Ko;Department of Pathology, Gyeongsang National University School of Medicine, Jinju, Republic of Korea

Jeong Hee Lee;Division of Hematology–Oncology, Department of Internal Medicine, Gyeongsang National University School of Medicine, Jinju, Republic of Korea

Dong Chool Kim;Institute of Health Science, Gyeongsang National University School of Medicine, Jinju, Republic of Korea

Dae Hyun Song;Gyeongnam Regional Cancer Center, Jinju, Republic of Korea

Jung Wook Yang;Department of Laboratory Medicine

Jong Sil Lee;Department of Pathology, Gyeongsang National University School of Medicine, Jinju, Republic of KoreaCorrespondence[email protected]

show all

Pages 1992-1998 | Received 16 Jun 2009, Accepted 05 Sep 2009, Published online: 08 Oct 2009

Cite this article
https://doi.org/10.3109/10428190903312462

Full Article
Figures & data
References
Citations
Metrics
Reprints & Permissions

References

Colvin M, Hilton J. Pharmacology of cyclophosphamide and metabolites. Cancer Treat Rep 1981;65:89–95.
PubMedGoogle Scholar
Pegg AE. Repair of O(6)-alkylguanine by alkyltransferases. Mutat Res 2000;462:83–100.
PubMed Web of Science ®Google Scholar
Robertson KD. DNA methylation, methyltransferases, and cancer. Oncogene 2001;20:3139–3155.
PubMed Web of Science ®Google Scholar
Santini V, Kantarjian HM, Issa JP. Changes in DNA methylation in neoplasia: pathophysiology and therapeutic implications. Ann Intern Med 2001;134:573–586.
PubMed Web of Science ®Google Scholar
Ludlum DB. DNA alkylation by the haloethylnitrosoureas: nature of modifications produced and their enzymatic repair or removal. Mutat Res 1990;233:117–126.
PubMed Web of Science ®Google Scholar
Pegg AE, Dolan ME, Moschel RC. Structure, function, and inhibition of O6-alkylguanine-DNA alkyltransferase. Prog Nucleic Acid Res Mol Biol 1995;51:167–223.
PubMed Web of Science ®Google Scholar
Esteller M, Gaidano G, Goodman SN, et al Hypermethylation of the DNA repair gene O(6)-methylguanine DNA methyltransferase and survival of patients with diffuse large B-cell lymphoma. J Natl Cancer Inst 2002;94:26–32.
PubMed Web of Science ®Google Scholar
Ohno T, Hiraga J, Ohashi H, et al Loss of O6-methylguanine-DNA methyltransferase protein expression is a favorable prognostic marker in diffuse large B-cell lymphoma. Int J Hematol 2006;83:341–347.
PubMed Web of Science ®Google Scholar
Frommer M, McDonald LE, Millar DS, et al A genomic sequencing protocol that yields a positive display of 5-methylcytosine residues in individual DNA strands. Proc Natl Acad Sci USA 1992;89:1827–1831.
PubMed Web of Science ®Google Scholar
Clark SJ, Harrison J, Paul CL, Frommer M. High sensitivity mapping of methylated cytosines. Nucleic Acids Res 1994;22:2990–2997.
PubMed Web of Science ®Google Scholar
Cheson BD, Pfistner B, Juweid ME, et al Revised response criteria for malignant lymphoma. J Clin Oncol 2007;25:579–586.
PubMed Web of Science ®Google Scholar
Trotti A, Colevas AD, Setser A, et al CTCAE v3.0: development of a comprehensive grading system for the adverse effects of cancer treatment. Semin Radiat Oncol 2003;13:176–181.
PubMed Web of Science ®Google Scholar
Esteller M, Hamilton SR, Burger PC, et al Inactivation of the DNA repair gene O6-methylguanine-DNA methyltransferase by promoter hypermethylation is a common event in primary human neoplasia. Cancer Res 1999;59:793–797.
PubMed Web of Science ®Google Scholar
Pike BL, Greiner TC, Wang X, et al DNA methylation profiles in diffuse large B-cell lymphoma and their relationship to gene expression status. Leukemia 2008;22:1035–1043.
PubMed Web of Science ®Google Scholar
Rossi D, Capello D, Gloghini A, et al Aberrant promoter methylation of multiple genes throughout the clinico-pathologic spectrum of B-cell neoplasia. Haematologica 2004;89:154–164.
PubMed Web of Science ®Google Scholar
Lee SM, Lee EJ, Ko YH, et al Prognostic significance of O6-methylguanine DNA methyltransferase and p57 methylation in patients with diffuse large B-cell lymphomas. APMIS 2009;117:87–94.
PubMedGoogle Scholar
Nakamichi I, Tomita Y, Zhang B, et al Correlation between promoter hypermethylation of GSTP1 and response to chemotherapy in diffuse large B cell lymphoma. Ann Hematol 2007;86:557–564.
PubMed Web of Science ®Google Scholar
Hiraga J, Kinoshita T, Ohno T, et al Promoter hypermethylation of the DNA-repair gene O6-methylguanine-DNA methyltransferase and p53 mutation in diffuse large B-cell lymphoma. Int J Hematol 2006;84:248–255.
PubMed Web of Science ®Google Scholar
Coiffier B, Lepage E, Briere J, et al CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large B-cell lymphoma. N Engl J Med 2002;346:235–242.
PubMed Web of Science ®Google Scholar
Habermann TM, Weller EA, Morrison VA, et al Rituximab-CHOP versus CHOP alone or with maintenance rituximab in older patients with diffuse large B-cell lymphoma. J Clin Oncol 2006;24:3121–3127.
PubMed Web of Science ®Google Scholar
Pfreundschuh M, Trümper L, Osterborg A, et al CHOP-like chemotherapy plus rituximab versus CHOP-like chemotherapy alone in young patients with good-prognosis diffuse large-B-cell lymphoma: a randomised controlled trial by the MabThera International Trial (MInT) Group. Lancet Oncol 2006;7:379–391.
PubMed Web of Science ®Google Scholar
Sehn LH, Donaldson J, Chhanabhai M, et al Introduction of combined CHOP plus rituximab therapy dramatically improved outcome of diffuse large B-cell lymphoma in British Columbia. J Clin Oncol 2005;23:5027–5033.
PubMed Web of Science ®Google Scholar
Fu K, Weisenburger DD, Choi WW, et al Addition of rituximab to standard chemotherapy improves the survival of both the germinal center B-cell-like and non-germinal center B-cell-like subtypes of diffuse large B-cell lymphoma. J Clin Oncol 2008;26:4587–4594.
PubMed Web of Science ®Google Scholar
Gerson SL. MGMT: its role in cancer aetiology and cancer therapeutics. Nat Rev Cancer 2004;4:296–307.
PubMed Web of Science ®Google Scholar

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Share icon
Back to Top

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references

Is inactivation of O⁶-methylguanine DNA methyltransferase still a favorable prognostic factor of patients with diffuse large B-cell lymphoma in the era of R-CHOP chemotherapy?

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Is inactivation of O6-methylguanine DNA methyltransferase still a favorable prognostic factor of patients with diffuse large B-cell lymphoma in the era of R-CHOP chemotherapy?

References

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date

Is inactivation of O⁶-methylguanine DNA methyltransferase still a favorable prognostic factor of patients with diffuse large B-cell lymphoma in the era of R-CHOP chemotherapy?